Obesity Surgery Devices Market - Global
Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Obesity
can be defined as a medical condition where excess fat deposition leads to
adverse health conditions. Obesity increases the chances of diseases related
with heart, certain type of cancer, diabetes and osteoarthritis. Obesity has
become one of the serious leading healthcare problems across the globe. It is
mainly caused by increased fatty intake, reduced physical exercises and
sometimes genetic inheritance. Physical exercise and diet management are the
main components for the treatment of obesity whereas anti-obesity drugs are
also available for fat reduction. However, sometimes diet control, exercise and
medication are not effective in weight reduction in such scenarios obese people
opt for surgical procedures for weight management. Obesity surgery treats
obesity by removal of a portion of the stomach or reduction in size of stomach
through application of gastric bands or sleeve gastrectomy.
To check out the complete table of
contents, visit: http://www.marketresearchreports.biz/analysis-details/obesity-surgery-devices-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
The
market for obesity surgical devices is driven by changing lifestyles, hectic work
schedules, less physical exercise and increasing uptake of fast food. As
estimated approximately 200 million adults are categorized as obese or
overweight and is resulting in 112,000 deaths annually. This presents an
enormous need for less invasive weight loss treatments. The obesity surgical
devices market is segmented on the basis of various surgery devices and type of
surgical procedures. Surgical devices segment comprises adjustable gastric
band, intragastric balloon, clip applier, surgical staples, trocars and others.
Surgical procedures section comprises restrictive procedures, malabsorptive
procedures and mixed procedures.
Geographically,
North America dominates the markets followed by Europe and Asia. This
dominance in North American region is being witnessed owing to rise in number
of obese patients and mounting public awareness. However, high procedural
costs are expected to restraint the market growth. On the contrary, growing
demand for less invasive procedures and obesity treatment has significantly
boosted the market growth. Similarly, increase in disposable income in
developing nations is also a major contributing factor towards market
growth.
Some
of the major players engaged in obesity surgical devices market include
Allergan, Inc., Covidien PLC, EnteroMedics, Inc., Cousin Biotech, Surgical IOC,
PARE Surgical and other key players.
This
research report analyzes this market depending on its market segments, major
geographies, and current market trends.
Geographies
analyzed under this research report include
- North
America
- Asia
Pacific
- Europe
- Rest of the
World
This
report provides comprehensive analysis of
- Market growth
drivers
- Factors limiting
market growth
- Current market
trends
- Market structure
- Market
projections for upcoming years
This
report is a complete study of current trends in the market, industry growth
drivers, and restraints. It provides market projections for the coming years.
It includes analysis of recent developments in technology, Porter’s five force
model analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
Reasons
for Buying this Report
- This report
provides pin-point analysis for changing competitive dynamics
- It provides a
forward looking perspective on different factors driving or restraining
market growth
- It provides a
technological growth map over time to understand the industry growth rate
- It provides a
seven-year forecast assessed on the basis of how the market is predicted
to grow
- It helps in
understanding the key product segments and their future
- It provides pin
point analysis of changing competition dynamics and keeps you ahead of
competitors
- It helps in
making informed business decisions by having complete insights of market
and by making in-depth analysis of market segments
- It provides
distinctive graphics and exemplified SWOT analysis of major market
segments
Latest Reports:
Apoptosis
Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,
2013 - 2019: http://www.marketresearchreports.biz/analysis-details/apoptosis-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Apoptosis
is a programmed natural process of cell death in the body which results from
natural stimuli in order to protect against viral infection, unusual cell
division and cells with damaged genetic material. However malfunctioning of
apoptosis can trigger uncontrolled and non regulated cell death related to
degenerative disorders such as Parkinson’s disease and Alzheimer’s. Defective
apoptosis process has been one of the most common and leading causes for cancer
wherein the affected cells instead of undergoing apoptosis continue to
proliferate and mutate. Thus development of apoptosis modulating drugs has
recently been witnessing spectacular growth in the treatment for cancer, CNS
diseases, and chronic inflammation or autoimmunity disorders.
The
global apoptosis market is categorized by:
Drug
class and consumables
- Direct
apoptogens
- First generation
indirect apoptogens
- Second
generation indirect apoptogens
- Reagents and
kits
Indications
- Cancer
- Cardiovascular
- Neurodegenerative
diseases
Currently,
North America dominates the global apoptosis market and is followed by Europe
due to existence of huge potential for apoptosis modulating therapeutics and
rising popularity of targeted cancer therapy. Emerging economies of
Asia-Pacific, Latin America, Middle East and Africa are also expected to
undergo rapid growth in the apoptosis market due to the rising incidences of
cancer and unmet treatment needs in such developing regions.
Biological Drugs Market - Global Industry
Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/biological-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Biological
drugs are biological medical products whose active drug substance is extracted
by using living organism. The active substance is derived from living organism
by the usage of recombinant DNA technology. These drugs offer better treatment
solutions than synthetic drugs owing to greater accuracy and fewer side
effects. Biological drugs are mainly made of monoclonal antibodies (mAbs) that
help to fight with the disease. Monoclonal antibodies have the capability of
targeting specific area in the body that requires drug treatment hence
producing accurate results. Majorly biologic drugs are given for the treatment
of diseases such as HIV/AIDS, Alzheimer’s diseases, cancers and others. Moreover,
biologic drugs are also expected to find a solution for the large portion of
retired population which is more prone to chronic diseases.
Global
biological drugs market is growing at substantial rate owing to the drug
accuracy and increase in chronic diseases. In addition, biologic drugs have
shown a better outcome in long term and offer a better quality of life. There
are approximately 150 biologic drugs commercially available in the markets
which are being used to treat diseases such as asthma, irritable bowel
syndrome, rheumatoid arthritis, cancer and others. For example, Avastin for the
treatment of lung cancer and Cerezyme for Gaucher disease are commercially
available and cost about USD 100,000 and USD 300,000 per year respectively.
However, half of the biological drugs are about to lose their patent protection
and as a result cheaper alternative biogeneric products are expected to enter
in to the market. On the contrary, cost of the biologic drugs is one the major
restraining factor for the growth of this market. Biologic drugs are costly as
compared to other drugs but are likely to become cheaper in near future. Owing
to the potential benefits of the biologic drugs they have been put on fast
track FDA approval process.
This
research report analyzes this market depending on its market segments, major
geographies, and current market trends. Geographies analyzed under this
research report include
- North
America
- Asia
Pacific
- Europe
- Rest of the
World
This
report provides comprehensive analysis of
- Market growth
drivers
- Factors limiting
market growth
- Current market
trends
- Market structure
- Market
projections for upcoming years
About Us
MarketResearchReports.Biz is the most comprehensive
collection of market research reports. MarketResearchReports.Biz services are specially
designed to save time and money for our clients. We are a one stop solution for
all your research needs, our main offerings are syndicated research reports,
custom research, subscription access and consulting services. We serve all
sizes and types of companies spanning across various industries.
Contact
M/s
Sheela
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
– Canada Toll Free: 866-997-4948
Blog:
http://industry-research-reports.blogspot.com/
